UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 4
April-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1904R75


Registration ID:
300384

Page Number

1184-1195

Share This Article


Jetir RMS

Title

Development and validation for the simultaneous estimation of Sofosbuvir and Ledipasvir by UV spectrophotometer method in bulk and tablet dosage forms

Abstract

Objective: In the present work, A Simple, rapid, sensitive, precise and reproducible specific UV spectrophotometric method for the determination of Sofosbuvir (SOFO) and Ledipasvir (LEDI) in bulk drug and pharmaceutical dosage form were developed and validated. Methods: A simple double beam UV spectrophotometric method has been developed and validated with different parameters such as linearity, precision, repeatability, limit of detection (LOD), Limit of Quantification (LOQ), accuracy as per ICH guidelines. Results: UV-visible Spectrophotometric method, measurement of absorption at maximum wavelength in 10 ml methanol and volume make with water solvent system as reference Sofosbuvir and Ledipasvir were found to be at 250 nm and 333 nm respectively. The drug obeyed the Beer’s law and showed good correlation. Beer’s law was obeyed in concentration range 8-40 µg/ml for Sofosbuvir and 2-10µg/ml for Ledipasvir respectively with correlation coefficient was 0.998. The LOD and LOQ of Sofosbuvir was found to be 0.047 μg/ml and 0.142 μg/ml, Ledipasvir were found to be 1.02 μg/ml and 3.11 μg/ml, respectively. Percentage assay of SOFO and LEDI in tablets. Conclusion: The proposed method is simple, precise, accurate and reproducible can be used for routine analysis of Sofosbuvir and Ledipasvir in bulk and tablet dosage form.

Key Words

Keywords: Sofosbuvir, Ledipasvir, Method development, Validation, UV spectrophotometric, Dosage forms.

Cite This Article

"Development and validation for the simultaneous estimation of Sofosbuvir and Ledipasvir by UV spectrophotometer method in bulk and tablet dosage forms", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 4, page no.1184-1195, April-2019, Available :http://www.jetir.org/papers/JETIR1904R75.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Development and validation for the simultaneous estimation of Sofosbuvir and Ledipasvir by UV spectrophotometer method in bulk and tablet dosage forms", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 4, page no. pp1184-1195, April-2019, Available at : http://www.jetir.org/papers/JETIR1904R75.pdf

Publication Details

Published Paper ID: JETIR1904R75
Registration ID: 300384
Published In: Volume 6 | Issue 4 | Year April-2019
DOI (Digital Object Identifier):
Page No: 1184-1195
Country: bhopal, M.P, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003067

Print This Page

Current Call For Paper

Jetir RMS